Ludwig Enterprises, Inc. (LUDG)

Market Cap	28.62M
Revenue (ttm)	13.25K
Net Income (ttm)	-3.31M
Shares Out	159.91M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Open	0.150
Previous Close	0.160
Day's Range	0.150 - 0.161
52-Week Range	0.071 - 0.430
Beta	2.67
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Ludwig Enterprises

Ludwig Enterprises, Inc. operates as a genomic technology and health related company. The company engages in the developing of products that use inflammatory genetic markers to assess the occurrence of inflammation and inflammation related diseases, as well as monitor treatment responses. It offers My RNA for Life Home Test Kits, that identify the potential to develop chronic inflammatory diseases, such as cancer and heart disease; and My RNA for Life Genetic Centric Supplement, that may modulate a person’s previously measured inflammatory inde...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: LUDG